Is Cabot Corporation (CBT) overvalued? · P/E 16, rev $3.71B
Cabot Corporation (CBT) is a specialty chemicals company listed on US.
This page asks whether Cabot Corporation (CBT) looks expensive on cached numbers — not a short thesis.
Latest reported CBT revenue for 2025-09-30 was $3.71B. Net income was $376.0M. Revenue was down 7.0% from 2024-09-30 to 2025-09-30. CBT currently screens at market cap $4.29B and trailing P/E 15.7.
CBT currently screens at market cap $4.29B and trailing P/E 15.7. A high multiple can be growth prepaid or a bubble. The filing has to explain the gap.
If the next CBT 8-K cuts growth or raises capex, this “expensive” read gets worse. Until then the SEC page is the source.
Not investment advice. Use the CBT stock page for the full model, not this heading.
Not investment advice.